Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,470,313
New position
Shares Held
7,754
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#580
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names. AZN ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,449 | $30,524,296 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
128,157 | $7,384,406 | |
| 3 | BIIB |
Biogen Inc.
|
20,649 | $4,461,422 | |
| 4 | PFE |
Pfizer Inc
|
173,689 | $4,182,431 | |
| 5 | AMGN |
Amgen Inc
|
8,927 | $3,232,645 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,216 | $2,933,109 | |
| 7 | NVS |
Novartis AG
|
9,740 | $1,526,452 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
7,754 | $1,470,313 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,470,313 | 7,754 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||